ARX vs NP: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

ARX and NP are similarly sized, but ARX trades noticeably cheaper on forward earnings (21.22x vs 41.61x): the market is paying up for NP's profile and pricing ARX more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.

ARX vs NP: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricARXNPWhat it tells you
Market cap$4.32B$3.88BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E21.2241.61Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Price vs 52-week range100% of range65% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.

Reading it: ARX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how ARX and NP affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARX and NP share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARX and NP exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Accelerant Holdings (ARX) do?

Accelerant Holdings operates a data-driven risk exchange for specialty insurance. On one side are managing general agents (MGAs), the specialist underwriters who design and sell niche insurance products; on the other are risk capital partners such as insurers, reinsurers, and institutional investors who put up the capital to back those policies. Accelerant sits in the middle, using proprietary technology, data, and machine learning to match risk with capital, share high-fidelity underwriting data, and monitor portfolios. It earns a fixed-percentage, volume-based fee for sourcing, managing, and monitoring the business written through the exchange, which spans more than 500 specialty insurance products across 22 countries. The company reports through three segments: Exchange Services, MGA Operations, and Underwriting, and describes its model as capital-light because it aims to retain only a small share of the premium risk (roughly 9% in 2025) and pass the rest to third-party capital.

Full ARX guide

What does Neptune Insurance Holdings (NP) do?

Neptune Insurance Holdings (NYSE: NP) is a St. Petersburg, Florida insurtech whose main subsidiary, Neptune Flood, is the largest private flood insurance seller in the United States. It operates as a managing general agent, meaning it uses its proprietary AI platform, Triton, to quote, underwrite, and issue residential and commercial flood policies on behalf of a panel of insurance-carrier and reinsurance partners, then earns commissions and fees rather than holding most of the underlying catastrophe risk on its own balance sheet. Triton runs without traditional human underwriters, processes roughly 20,000 quotes on a typical day, and had generated more than 29.7 million lifetime quotes and bound over 1.1 million policies as of mid-2025, with a lifetime written loss ratio around 24.7%. Neptune also offers excess flood coverage and has begun beta-testing parametric and indemnity earthquake products.

Full NP guide

ARX vs NP: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • ARX drivers: The Thoma Bravo deal sets the price; Go-shop ended with no rival bid.
  • NP drivers: Share shift from the federal NFIP; Technology-driven margin and scale.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: With a signed all-cash agreement, the main risk is deal completion. For NP, the central risks are catastrophe and reinsurance related.

ARX or NP: which should you pick?

Pick ARX if you believe its drivers more; NP if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARX and NP guides.

ARX vs NP: the full fundamentals

ARX. Since August 13, 2026 ARX has been valued by the Thoma Bravo offer, not by earnings multiples. At $19.75 the shares trade about 2.5% below the $20.25 cash price, a spread that reflects the time until the expected first-half 2027 close and the chance the deal does not complete. Measures such as about 4 times TTM sales or 21 times forward earnings describe what the buyer is paying rather than where the stock is likely to trade before closing.

NP. Figures are approximate and tied to the asOf date; verify live numbers before acting. NP trades at a steep growth multiple, roughly 127x trailing and 43x forward earnings, which reflects investor expectations for continued premium-in-force growth and high agency margins rather than a mature insurer's valuation. The 52-week range (about $14.78 to $35.15) shows how much the stock has moved since its October 2025 IPO, and third-quarter results on October 20, 2026 face a consensus near $0.16 of EPS on about $56.4 million of revenue.

Headline figures (approximate, October 2026): ARX shows deal price (thoma bravo, all cash) $20.25 per share; enterprise value >$4 billion, share price / spread to deal $19.75 (Oct 16, 2026) / ~2.5%, expected close First half of 2027, revenue (ttm) ~$1.07 billion; NP shows revenue (ttm) ~$182 million, revenue (q2 2026 quarterly) ~$55.9 million, up ~33% year over year, net income (ttm) ~$37 million (Q2 2026: ~$15.8 million), margins (operating / net, ttm) ~48% / ~21%.

The bottom line: ARX vs NP

ARX and NP are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ARX and NP exposure against your real portfolio. It is not an investment adviser.

Wondering how ARX or NP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Accelerant Holdings

Ask Walnut's AI anything about ARX and see how it fits what you own.

FAQ

What is the difference between ARX and NP?

+

Accelerant Holdings operates a data-driven risk exchange for specialty insurance. Neptune Insurance Holdings (NYSE: NP) is a St. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ARX or NP the better stock?

+

Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ARX or NP?

+

On forward P/E (as of November 2026), ARX trades at 21.22x and NP at 41.61x, so ARX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ARX and NP?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ARX vs NP?

+

ARX: With a signed all-cash agreement, the main risk is deal completion. Shareholder approval, regulatory approvals for an insurance business, financing and other conditions could delay or block the transaction, and the expected close in the first half of 2027 leaves months for something to change. If the deal failed, the stock would likely fall back toward a price set by fundamentals; it traded near $13 in July 2026, before the announcement-day jump of about 43%. The upside is capped near $20.25 unless a higher bid appears, and the go-shop ended without one. Holders also bear the time value of waiting: a roughly 2.5% spread over several months is a modest return for that risk. The underlying business risks still apply to a broken-deal scenario: a capital-light model unproven across a full insurance cycle, dependence on keeping MGAs and capital partners engaged, a large reported net loss tied to the IPO, and cyclical specialty insurance pricing. NP: The central risks are catastrophe and reinsurance related. Neptune concentrates in a single, weather-exposed line, so a severe flood season or a string of major storms could spike losses and, more importantly for an agency model, raise the cost or reduce the availability of the reinsurance capacity it depends on. Its economics are also tied to the political fate of the NFIP, whose periodic reauthorization and reform can shift competition in either direction. As a recently public, founder-controlled company (CEO Trevor Burgess holds around 82% of voting power), minority shareholders have limited say, and the roughly 127x trailing P/E (about 43x forward) leaves little room for disappointment if growth or margins slow. Insiders have also been selling: SEC filings in September and October 2026 showed sales worth roughly $1.6 million and $1.1 million. The balance sheet carries about $240 million of debt against roughly $18 million of cash. Widening loss ratios, higher acquisition costs from new competitors, and regulatory changes across states are additional pressures.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ARX or NP; figures are approximate and dated (as of November 2026). Verify current data before investing.